Buspirone Hydrochloride

Product NDC
70518-2303
11-digit product format
705182303
Labeler code
70518
Product ID
70518-2303_c81dbcdd-40df-056e-e053-2995a90a96c9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
buspirone hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA075467
Marketing category
ANDA
Marketing start
2019-09-09
Marketing end
0000-00-00
Substance
BUSPIRONE HYDROCHLORIDE
Active strength
8 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2303-02023-03-09C16284748780-1f386c64a-3fe0-0266-e053-dadaa90a7c1a99fc2ae2-4b32-4ef5-8af9-3153942ef1ef
70518-2303-02023-01-30C16284748780-1f386c64a-3fe0-0266-e053-dadaa90a7c1a99fc2ae2-4b32-4ef5-8af9-3153942ef1ef

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2303-07051823030030 TABLET in 1 BLISTER PACK (70518-2303-0) 30 tablet2019-09-090000-00-00NoNoCurrent